In the other NSCLC histological types KRAS mutation frequency was 3% in squamous cell carcinomas (2 out of 66, Table 3) and 19% in NOS and other histologies (25 out of 105 Fig 2). The gene discussed is KRAS; the disease is squamous cell carcinoma.